Obesity Epidemic Requires More NIH Research, Drug Development – AOA
This article was originally published in The Tan Sheet
Executive Summary
The American Obesity Association is asking Congress to prioritize obesity-related health concerns by establishing a new NIH institute that would concentrate solely on research related to the condition
You may also be interested in...
Glaxo Claims OTC Switch Dominance With An Eye Toward Xenical In 2006
GlaxoSmithKline believes an OTC switch of the prescription weight-loss drug Xenical (orlistat) could have the same success as its nonprescription nicotine replacement therapy offerings
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands